Chopo

What Chopo does

Chopo (legal name: Grupo Diagnóstico Médico Proa, S.A. de C.V., doing business as Laboratorio Médico del Chopo) is a privately held Mexican clinical diagnostics company founded circa 1947–1949 that operates more than 750 patient service branches across 30 Mexican regions (Norte, Centro, Sur). Its core business is providing clinical laboratory analysis and diagnostic imaging studies to individual patients, referring physicians, and corporate clients, supported by a centralized reference laboratory called CARPEMOR (Laboratorio de Referencia de Chopo) that holds ISO 9000, CAP, and NGSP certifications. The company offers more than 2,300 studies spanning clinical chemistry, hematology, immunology, microbiology, molecular biology (including rRT-PCR for SARS-CoV-2), cytogenetics, genetic panels (NIPT, hereditary cancer NGS, CytoScan HD microarray), and a full imaging suite (ultrasound, MRI, CT, mammography, X-ray).

Revenue is generated primarily through per-study unit pricing (pay-as-you-go) for individual tests and bundled Check-up packages, supplemented by corporate health screening programs (subscription-style enterprise contracts), home sample collection fees, and loyalty-driven repeat business via the Vida Sana program (four tiers, Azul through Avanzado, with up to 30% clinical analysis discount). The go-to-market is omnichannel: walk-in branch visits (open from 6:00 AM), website e-commerce with 10–30% digital-only discounts, iOS/Android mobile app for booking and payment, call center (55 1104 4880 / 800 00 24676), and a dedicated physician portal (Nube Chopo / Chopo Médicos) that drives referral volume. Payment options include Meses Sin Intereses (MSI) installment plans for purchases over MXN $3,500.

The business model blends high-volume, low-ticket commodity bloodwork with higher-margin specialty molecular and genetic testing, imaging, and corporate accounts. Geographic coverage is national within Mexico but does not extend internationally; the company is privately held with no disclosed external funding rounds, M&A activity, or leadership changes, suggesting self-funded or family/local ownership under the Grupo Diagnóstico Médico Proa corporate umbrella.

Name

Chopo

Legal name

Grupo Diagnóstico Médico Proa, S.A. de C.V.

Website

https://chopo.com.mx

Company type

Private

Founded year

1949

Operating status

Operating

Headcount range

501–1,000 employees

Short description

Chopo (Laboratorio Médico del Chopo) is a Mexican clinical diagnostics company operating 750+ branches across 30 regions, offering 2,300+ laboratory and imaging studies to individual patients, referring physicians, and corporate clients via an omnichannel model including branches, mobile app, and physician portal.

Ownership category

akta.pro rank

Product category

Clinical Laboratory and Diagnostic Imaging Services

NAICS

Medical and Diagnostic Laboratories (6215)

SIC

Services-Medical Laboratories (8071)

akta.pro primary industry

Central Laboratory & Clinical Trial Testing CROs (HLAGAAAE)

akta.pro secondary industry

Hematology & Coagulation Laboratories (HLAFAMAC)

Keywords

• Clinical laboratory services
• Diagnostic imaging services
• Preventive health check-ups
• Molecular diagnostic testing
• Medical testing services

Headquarters

HQ city

Cuauhtémoc

HQ country

Mexico

HQ region

Latin America

Offices33 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Supply Chain, Technology or R&D, Marketing or Sales

Revenue model

1. Clinical Laboratory Analysis Services: Core revenue from blood tests, urine analysis, and other routine laboratory studies performed at branches. Pricing varies by study complexity with individual tests and bundled profiles/packages available.
2. Imaging and Cabinet Studies: Revenue from diagnostic imaging services including ultrasound, MRI, CT scans, X-ray, mammography, and specialized imaging like multiparametric prostate MRI and whole-body diffusion MRI.
3. Check-up Packages and Profiles: Bundled health screening packages combining multiple tests at discounted prices compared to individual tests. Includes preventive check-ups, thyroid profiles, diabetes control packages, and gender-specific profiles.
4. Corporate and Enterprise Services: Business services including employee health screening programs, corporate accounts, and insurance/aseguradora partnerships for organizational clients.
5. Home Collection Services: Mobile phlebotomy and sample collection services at patient homes or workplaces, with additional charges for convenience.
6. Vida Sana Loyalty Program: Free loyalty program offering progressive discounts (20-30% on clinical analysis, 15-25% on imaging, 10-20% on specialty studies) based on visit frequency and tier level (Azul, Esencial, Intermedio, Avanzado).

Pricing tiers

Go-to-market motion3 records

Distribution channels7 records

Marketing channels10 records

Core offering

Chopo (Laboratorio Médico del Chopo) operates a nationwide clinical laboratory and diagnostic imaging service in Mexico, performing more than 2,300 studies including blood chemistry, hematology, immunology, microbiology, molecular biology, cytogenetics, and genetic testing, alongside cabinet imaging such as MRI, CT, ultrasound, mammography, and X-ray. Customers access these services through 750+ physical branches, the company's e-commerce website, the Chopo Mobile app, a call center, and a home sample-collection service, with results delivered digitally through the patient portal and Nube Chopo physician portal.

Product overview

Laboratorio Médico del Chopo operates as a comprehensive medical diagnostic laboratory offering a unified platform of clinical laboratory testing and diagnostic imaging services across over 750 branches in Mexico. The core product portfolio centers on two integrated service lines: (1) Análisis Clínicos encompassing blood chemistry, hematology, immunology, microbiology, molecular biology, and genetic testing, and (2) Estudios de Gabinete comprising imaging modalities including ultrasound, MRI, CT scans, mammography, and conventional X-ray. The offering is structured around flagship sub-products such as the Química Integral de 45 Elementos panel, preventive Check-up packages, COVID-19 testing services, and specialized panels for thyroid function, diabetes monitoring (Hemoglobina Glicosilada A1C), sexually transmitted infections, and prenatal screening (NIPT). Supporting the core diagnostic services, Chopo provides complementary digital platforms including the App Chopo Mobile for appointment scheduling and mobile payments, the Nube Chopo physician portal for result access, and a Vida Sana loyalty program. Additional services include home sample collection, corporate health programs, electronic invoicing, and an online results portal, creating a multi-channel diagnostic ecosystem serving both patients and healthcare providers.

Differentiator

Problem solved

Functional benefit

Brands

• Vida Sana: A free loyalty program for patients that provides discounts on clinical analysis, imaging studies, and high-specialty studies, with tiered membership levels (Azul, Esencial, Intermedio, Avanzado).
• Chopo Médicos

Products and services

• Análisis Clínicos (Clinical Laboratory Tests) Core clinical laboratory testing service covering blood chemistry, hematology, urinalysis, immunology, microbiology, molecular biology, cytogenetics, and genetic panels, performed at Chopo's 750+ branches across Mexico for individual patients, referring physicians, and corporate accounts.
• Estudios de Gabinete (Diagnostic Imaging Studies) Diagnostic imaging service including ultrasound, MRI (cranial, cervical/lumbar spine, knee, shoulder, whole-body diffusion), CT scan (head, chest, abdomen, paranasal sinuses), conventional X-ray, and specialized studies such as multiparametric prostate MRI, performed at Chopo branches with appointment-based scheduling.
• Check-ups Preventivos (Preventive Health Packages) Pre-bundled preventive screening packages such as CHECK-UP BÁSICO Q45, CHECK-UP INTEGRAL Q45, CHECK-UP BASICO TIROIDEO Q45, PAQUETE CONTROL DIABETES Q45, and gender-specific profiles, combining multiple tests at discounted rates for routine health monitoring.
• Pruebas COVID-19 (COVID-19 Testing) COVID-19 diagnostic testing services including PCR, antigen, and antibody tests offered at branches and via home collection, using the WHO/InDRE-recommended Charité rRT-PCR protocol at the CARPEMOR reference laboratory.
• Test Prenatal No Invasivo (NIPT) Non-invasive prenatal screening for aneuploidies and microdeletions using cell-free fetal DNA analysis, offered as a standalone genetic screening service for pregnant patients.
• Mastografía (Mammography) Breast imaging screening and diagnostic mammography service for early breast cancer detection, available as a standalone imaging study for female patients.
• Panel Cáncer Hereditario NGS Next-generation sequencing panel for hereditary cancer risk assessment covering multiple cancer susceptibility genes, offered as a standalone genetic test for at-risk patients and physician referrals.
• Microarray Genómico (CytoScan HD) Advanced genomic microarray testing (CytoScan OPTIMA for prenatal, CytoScan HD for abortive products and genomic applications, OncoScan for oncological conditions) for detecting chromosomal abnormalities, genetic disorders, and copy number variations.
• Panel Enfermedades de Transmisión Sexual (14 Patógenos) Comprehensive 14-pathogen sexually transmitted infection panel using molecular diagnostics, covering HIV, syphilis, Chlamydia, gonorrhea, HPV, and additional pathogens in a single screening offering.
• Servicio a Domicilio (Home Sample Collection) Mobile phlebotomy and home sample collection service for laboratory tests (blood, urine, stool), enabling patients to have samples taken at their residence or workplace for an additional charge, with results delivered digitally through the patient portal.
• Servicios para Empresas (Corporate Health Services) Dedicated corporate healthcare services including employee health screening programs, pre-employment examinations, and business partnerships with insurance providers (aseguradoras), sold under recurring enterprise billing and invoicing arrangements to Mexican companies and insurers.

Quantifiable outcome

• 750+ branches providing nationwide coverage in Mexico
• +3 more outcomes

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Scale indicators8 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Quest Diagnostics: U.S.-headquartered clinical laboratory giant offering routine and advanced diagnostic testing to patients, physicians, and employers. Comparable in test menu breadth, physician portal, and corporate health channel, but operates primarily in North America at much larger scale.
• SYNLAB: Europe-based clinical laboratory services group with growing presence in Latin America. Comparable in clinical testing operations, central reference lab model, and quality accreditation approach, but operates globally with broader portfolio.
• Laboratory Corporation of America (Labcorp): U.S.-based clinical laboratory and diagnostics provider with extensive routine and specialty test menu, patient service centers, and physician digital tools. Comparable clinical diagnostics model and patient/physician channel mix, scaled globally.

Direct peers

• Salud Digna: Mexico's largest low-cost clinical diagnostic chain with a similarly extensive branch network and broad clinical test menu. Directly comparable in target customer, business model, and omnichannel distribution.
• Diagnóstico Integral (DI): Mexican diagnostic laboratory network providing clinical analysis, imaging, and preventive check-ups across multiple branches. Directly comparable in service mix, branch-based distribution, and B2C/B2B go-to-market.
• Laboratorios Olarte y Akle (LAPI): Mexican clinical laboratory chain providing análisis clínicos, gabinete/imaging, and specialty testing through multiple branches. Closely comparable patient-facing diagnostic model in the same Mexican market.
• Referencia Lab: Mexican reference laboratory offering centralized clinical testing, molecular diagnostics, and specialty panels for both patients and physicians. Comparable in central reference lab architecture and test menu breadth.

Emerging players

• Medix: Mexico-based health technology and preventive care platform offering diagnostics, telehealth, and corporate wellness. Comparable in corporate health and preventive testing offerings, but more digitally native and earlier-stage.

Others

• Doctoralia: Online healthcare marketplace in Mexico connecting patients with physicians and supporting appointment booking. Adjacent to Chopo's Nube Chopo physician portal and online appointment funnel, but not a direct diagnostic competitor.

Regional players

• Unilabs: European clinical diagnostics group operating a hub-and-spoke central laboratory model serving multiple European geographies. Architecturally comparable to Chopo's central reference lab plus collection network, though geographically distinct.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/LabMedicoChopo
• YouTubeyoutube.com/channel/UC6_pUTEeQ76kiZsjeu7gHJg
• Facebookfacebook.com/LabMedicoChopo
• Instagraminstagram.com/labmedicochopo
• LinkedInlinkedin.com/company/laboratorios-medico-chopo-sa-de-cv

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Chopo